Board Appointment

RNS Number : 3210L

Omega Diagnostics Group PLC

27 April 2015

 

OMEGA DIAGNOSTICS GROUP PLC

("Omega" or the "Company" or the "Group")

Board Appointment

Omega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces that Colin King has agreed to join the Board as Chief Operating Officer and will take up his appointment with effect from 3 August 2015.

Mr King has over 20 years' experience in the in-vitro diagnostics industry and is currently the Managing Director of Axis-Shield Diagnostics, having joined in 1995 and held a number of positions encompassing project management, operations, planning and supply chain logistics.

Andrew Shepherd, Chief Executive of the Company said:"We would like to welcome Colin to the Board. He brings a wealth of relevant industry experience and his depth of knowledge of the in-vitro diagnostics sector will further strengthen the Omega Board."

The following information is disclosed pursuant to Schedule Two paragraph (g) of the AIM Rules for Companies:

Mr Colin King, age 46

Current Directorships / Partnerships:

None

Previous Directorships / Partnerships (held in the past five years)

Axis-Shield Diagnostics Ltd

Axis-Shield Limited

Axis-Shield Laboratory Products

Mr King does not currently hold any ordinary shares in the Company.  There are no other disclosures required in relation to Rule 17 or paragraph (g) of Schedule 2 of the AIM Rules for Companies.

Contacts: 

Omega Diagnostics Group PLC	Tel: [phone] or www.omegadiagnostics.com
Andrew Shepherd, Chief Executive
Kieron Harbinson, Group Finance Director    Jag Grewal, Group Sales and Marketing Director
finnCap Ltd	Tel: [phone]
Geoff Nash/James Thompson (Corporate Finance) Mia Gardner (Corporate Broking)
Walbrook PR Limited	Tel: [phone] or [e-mail]
Paul McManus	Mob: [phone]
Lianne Cawthorne	Mob: [phone]

 

END

 

 

BOAFMGZDKDGGKZM